What’s New

Latest News

PharmLaw
Ahold Delhaize USA to Pay $40 Million in Drug Price Claims Settlement
06/16/2026
Grace Taylor, MS, MA
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay...
06/16/2026
Pharmacy Learning Network
Pharmacy Learning Network
News
HCC Surveillance Rates Declined During COVID-19 and Remain Low in the Post-Pandemic Era
06/16/2026
Rebecca Amrick
Hepatocellular carcinoma (HCC) surveillance decreased during the COVID-19 pandemic, and rates have not yet rebounded to pre-pandemic levels, sparking concern among researchers and calling for a need to expand care access and implement...
Hepatocellular carcinoma (HCC) surveillance decreased during the COVID-19 pandemic, and rates have not yet rebounded to pre-pandemic levels, sparking concern among researchers and calling for a need to expand care access and implement...
Hepatocellular carcinoma (HCC)...
06/16/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
News
Anti T-Lymphocyte Globulin Remains Standard GVHD Prophylaxis Following Unrelated Donor Transplantation
06/16/2026
Emily Estrada
Results from a phase 3 trial demonstrated that post-transplant cyclophosphamide did not achieve noninferiority to anti–T-lymphocyte globulin for overall survival following unrelated donor alloHCT in patients with high-risk myeloid...
Results from a phase 3 trial demonstrated that post-transplant cyclophosphamide did not achieve noninferiority to anti–T-lymphocyte globulin for overall survival following unrelated donor alloHCT in patients with high-risk myeloid...
Results from a phase 3 trial...
06/16/2026
Oncology
Oncology
News
Talquetamab Shows Lower Cost Per Response in Relapsed or Refractory Multiple Myeloma
06/16/2026
Lisa Kuhns, PhD, MD
Talquetamab delivered more than double the response rate of usual care while lowering the cost per responder, highlighting its potential economic and clinical value for heavily pretreated patients with relapsed or refractory multiple myeloma.
Talquetamab delivered more than double the response rate of usual care while lowering the cost per responder, highlighting its potential economic and clinical value for heavily pretreated patients with relapsed or refractory multiple myeloma.
Talquetamab delivered more than...
06/16/2026
First Report Managed Care
First Report Managed Care
News
AI-Based Risk Stratification Proves Cost-Effective for Diabetic Kidney Disease in Veterans
06/15/2026
Rebecca Amrick
An artificial intelligence (AI)-powered kidney disease risk stratification tool may offer a cost-effective way to improve outcomes for veterans with diabetic kidney disease, despite slightly higher upfront care costs.
An artificial intelligence (AI)-powered kidney disease risk stratification tool may offer a cost-effective way to improve outcomes for veterans with diabetic kidney disease, despite slightly higher upfront care costs.
An artificial intelligence...
06/15/2026
Veterans Health Today
Veterans Health Today
sunscreen
News
FDA Approves Bemotrizinol: What Dermatologists Need to Know
06/11/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr...
06/11/2026
The Dermatologist
The Dermatologist
Research Review
Artificial Sweeteners and Emulsifier Metabolites Linked to Crohn’s Disease Activity
06/11/2026
Jessica Garlewicz
In the first human study to demonstrate distinct P-80 metabolism in patients with Crohn's disease, researchers found that "dietary sweeteners and P-80 metabolites showed significant correlations with disease activity.”
In the first human study to demonstrate distinct P-80 metabolism in patients with Crohn's disease, researchers found that "dietary sweeteners and P-80 metabolites showed significant correlations with disease activity.”
In the first human study to...
06/11/2026
Advances in Inflammatory Bowel Disease Network
Advances in Inflammatory Bowel Disease Network

Latest Research

June 2026 issue
The Dermatologist
To Screen or Not to Screen? Rethinking Biologic Monitoring in the Modern Era
Vol. 34, Issue 4, Issue June 2026
CLD May/June 2026
Cath Lab Digest
Thrombus Burden in ALI and the Role of the Rotarex™ Catheter System
Vol. 34, Issue 3, Issue June 2026

HMP Global Learning Network

Featured Interviews

DLBCL, Diffuse Large B-Cell Lymphoma
Videos
Real-World Survival Impact of CAR T Therapy in Advanced DLBCL: Findings From a SEER Database Analysis: Part 2
05/27/2026
Nishanth Thalambedu, MD
This discussion explores the ongoing barriers to CAR T access and the strategies needed to expand equitable treatment for patients with diffuse large B-cell lymphoma (DLBCL).
This discussion explores the ongoing barriers to CAR T access and the strategies needed to expand equitable treatment for patients with diffuse large B-cell lymphoma (DLBCL).
This discussion explores the...
05/27/2026
Journal of Clinical Pathways
Bruce Sands
Expert Insights
Bruce Sands, MD, on Results from DUET-CD
05/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
05/19/2026
Advances in Inflammatory Bowel Disease Network
pediatric asthma
Videos
Pediatric Video Tutorial: Pediatric Asthma
05/19/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
Listening for wheezing is good, but asking two simple questions and listening to them talk can be even better.
Listening for wheezing is good, but asking two simple questions and listening to them talk can be even better.
Listening for wheezing is good,...
05/19/2026
EMSWorld
CTP News Desk Image
Viewpoints
Skin Substitute Reimbursement Changes 2026: MAC Denials, Q Codes, and What’s Next
05/19/2026
Daniel L. Kapp, MD
Daniel Kapp, MD, shares his observations on conflicting Medicare contractor guidance and coding confusion in early 2026 have effectively halting reimbursement for skin substitute applications in one MAC. 
Daniel Kapp, MD, shares his observations on conflicting Medicare contractor guidance and coding confusion in early 2026 have effectively halting reimbursement for skin substitute applications in one MAC. 
Daniel Kapp, MD, shares his...
05/19/2026
Wounds
CTP News Desk Image
Viewpoint
Operational Observations in a New CTP Regulatory Environment
05/08/2026
Nikki Johnston; Kati Kaushal, DNP, FNP-C, CWS
Learn more about these consultants' observations in this new regulatory environment.
Learn more about these consultants' observations in this new regulatory environment.
Learn more about these...
05/08/2026
Wounds
Advances in Charcot Neuroarthropathy Surgical Techniques Video
Videos
Advances in Charcot Neuroarthropathy Surgical Techniques Video
05/01/2026
Zeeshan S. Husain, DPM, FACFAS, FASPS; Athanasios Garbis, DPM; Kyle Lawton, DPM
In this video, we highlight emerging reconstruction strategies that move beyond traditional rigid fixation toward a more functional approach to limb preservation.
In this video, we highlight emerging reconstruction strategies that move beyond traditional rigid fixation toward a more functional approach to limb preservation.
In this video, we highlight...
05/01/2026
Podiatry Today
Jonathan Friedberg, MD
Videos
Nivolumab Plus Doxorubicin, Vinblastine, and Dacarbazine in Advanced Hodgkin Lymphoma
04/30/2026
Jonathan W. Friedberg, MD, MMSc
Jonathan Friedberg, MD, MMSc, discusses results from the SWOG S1826 trial which led to the recent FDA approval of nivolumab plus doxorubicin, vinblastine, and dacarbazine for patients with advanced-stage Hodgkin lymphoma.
Jonathan Friedberg, MD, MMSc, discusses results from the SWOG S1826 trial which led to the recent FDA approval of nivolumab plus doxorubicin, vinblastine, and dacarbazine for patients with advanced-stage Hodgkin lymphoma.
Jonathan Friedberg, MD, MMSc,...
04/30/2026
Oncology
Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
First Report Managed Care
Rachid Baz, MD
Videos
BCMA-Targeted Bispecifics and CAR-T in Frontline Multiple Myeloma
03/31/2026
Rachid Baz, MD
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the...
03/31/2026
Oncology
Al B. Benson, III, MD, FACP, FASCO
Videos
First-Line Immunotherapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC): Evidence Review
03/31/2026
Al B. Benson, III, MD, FACP, FASCO
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the...
03/31/2026
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use